NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a single, smarter surgery spare bladder cancer patients a second operation?
Disease control Recruiting nowThis study compares two approaches for treating non-muscle invasive bladder cancer. The standard approach uses two surgeries: one to remove the tumor and a second to check for leftover cancer. The new approach uses a single, enhanced surgery with a special dye and light to better…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE4 • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
Immunotherapy vs chemo: new hope for bladder cancer patients?
Disease control Recruiting nowThis study compares two treatments for a type of bladder cancer that hasn't spread into the muscle. One group gets the immunotherapy drug pembrolizumab plus radiation, while the other gets standard chemotherapy plus radiation. The goal is to see which combination better prevents …
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
New drug combo aims to control bladder cancer when standard therapy fails
Disease control Recruiting nowThis study tests two drugs, durvalumab and monalizumab, given together to people with a type of bladder cancer that has not gotten better with standard treatment. The goal is to see if the combination can make the cancer disappear or stop it from growing. About 60 adults will tak…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: John Sfakianos • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New injection targets bladder tumors in early trial
Disease control Recruiting nowThis early-stage study is testing whether a new drug, belzupacap sarotalocan, can be safely injected directly into bladder tumors. The trial involves about 55 people with non-muscle-invasive bladder cancer. Researchers will monitor side effects and check if the treatment helps sh…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 28, 2026 12:03 UTC
-
New DNA test may catch bladder cancer that scopes miss
Diagnosis Recruiting nowThis study is testing whether a combined blood and urine DNA test can detect muscle-invasive bladder cancer that standard scoping exams might miss before bladder removal surgery. About 92 adults scheduled for cystectomy will provide samples to see if the test accurately predicts …
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Sponsor: Fox Chase Cancer Center • Aim: Diagnosis
Last updated Jun 08, 2026 13:04 UTC
-
Can a prostate drug slow bladder cancer? new study investigates
Knowledge-focused Recruiting nowThis early-stage trial is testing whether bicalutamide, a drug typically used for prostate cancer, can change a protein linked to bladder cancer growth. About 80 adult men with non-invasive bladder cancer will either receive the drug or no study drug. The goal is to see if the dr…
Matched conditions: NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC